Literature DB >> 22411205

Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.

Sébastien Gaujoux1, Javiera Torres, Sara Olson, Corrine Winston, Mithat Gonen, Murray F Brennan, David S Klimstra, Michael D'Angelica, Ronald DeMatteo, Yuman Fong, Michael House, William Jarnagin, Robert C Kurtz, Peter J Allen.   

Abstract

BACKGROUND: Epidemiologic studies have reported a positive correlation between body mass index (BMI) and pancreatic cancer risk, but clinical relevance of obesity and/or body fat distribution on tumor characteristics and cancer-related outcome remain controversial. We sought to assess the influence of obesity and body fat distribution on pathologic characteristics and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
METHODS: Demographic and biometric data were collected on 328 patients undergoing pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. In a subset of patients, pancreatic fatty infiltration and fibrosis were assessed pathologically, and visceral fat area (VFA) was evaluated. Influence of BMI and body fat distribution on tumor characteristics and survival were evaluated.
RESULTS: A significant positive correlation between BMI and VFA was observed, with a wide range of VFA value within each BMI class. According to BMI or VFA distribution, there were no significant differences in patient characteristics, intraoperative or perioperative outcome, or pathologic characteristics, with the exception of significantly higher blood loss in patients with an increased body weight or VFA. Unadjusted overall and disease-free survival between BMI class and VFA quartile were not significantly different.
CONCLUSIONS: In this study, obesity and body fat distribution were not correlated with specific tumor characteristics or cancer-related outcome.

Entities:  

Mesh:

Year:  2012        PMID: 22411205     DOI: 10.1245/s10434-012-2301-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  21 in total

1.  Impact of body mass index for patients undergoing pancreaticoduodenectomy.

Authors:  Marco Del Chiaro; Elena Rangelova; Christoph Ansorge; John Blomberg; Ralf Segersvärd
Journal:  World J Gastrointest Pathophysiol       Date:  2013-05-15

2.  Metabolic and morphological measurements of subcutaneous and visceral fat and their relationship with disease stage and overall survival in newly diagnosed pancreatic adenocarcinoma : Metabolic and morphological fat measurements in pancreatic adenocarcinoma.

Authors:  Christophe Van de Wiele; Mathias Van Vlaenderen; Ludovic D'Hulst; Anne Delcourt; Dominique Copin; Bart De Spiegeleer; Alex Maes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-10-11       Impact factor: 9.236

3.  Analysis on survival and prognostic factors in patients with resectable pancreatic adenocarcinoma.

Authors:  Rong Lin; Chao-Qun Han; Wei-Jun Wang; Jun Liu; Wei Qian; Zhen Ding; Xiao-Hua Hou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

4.  Visceral and subcutaneous fat as new independent predictive factors of survival in locally advanced gastric carcinoma patients treated with neo-adjuvant chemotherapy.

Authors:  Xiao-Ting Li; Lei Tang; Ying Chen; Yan-Ling Li; Xiao-Peng Zhang; Ying-Shi Sun
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-24       Impact factor: 4.553

Review 5.  Excess Body Weight and Pancreatic Disease.

Authors:  Mats L Wiese; Ali A Aghdassi; Markus M Lerch; Antje Steveling
Journal:  Visc Med       Date:  2021-07-09

Review 6.  Adiposity and cancer survival: a systematic review and meta-analysis.

Authors:  Elizabeth M Cespedes Feliciano; Bette J Caan; En Cheng; Jocelyn Kirley
Journal:  Cancer Causes Control       Date:  2022-08-15       Impact factor: 2.532

7.  A comprehensive assessment of transfusion in elective pancreatectomy: risk factors and complications.

Authors:  Raphael C Sun; Anna M Button; Brian J Smith; Richard F Leblond; James R Howe; James J Mezhir
Journal:  J Gastrointest Surg       Date:  2013-02-20       Impact factor: 3.452

8.  Sarcopenia, but not visceral fat amount, is a risk factor of postoperative complications after major hepatectomy.

Authors:  Takaaki Higashi; Hiromitsu Hayashi; Katsunobu Taki; Keita Sakamoto; Hideyuki Kuroki; Hidetoshi Nitta; Daisuke Hashimoto; Akira Chikamoto; Toru Beppu; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2015-09-04       Impact factor: 3.402

9.  Outcome after neoadjuvant chemoradiation and correlation with nutritional status in patients with locally advanced pancreatic cancer.

Authors:  P Naumann; D Habermehl; T Welzel; J Debus; S E Combs
Journal:  Strahlenther Onkol       Date:  2013-07-31       Impact factor: 3.621

10.  Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma.

Authors:  Yuhei Hamaguchi; Toshimi Kaido; Shinya Okumura; Atsushi Kobayashi; Hisaya Shirai; Siyuan Yao; Shintaro Yagi; Naoko Kamo; Satoru Seo; Kojiro Taura; Hideaki Okajima; Shinji Uemoto
Journal:  Liver Cancer       Date:  2018-06-05       Impact factor: 11.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.